Epidemiology of Methicillin‐Resistant \u3cem\u3eStaphylococcus aureus\u3c/em\u3e Bacteremia in Gaborone, Botswana by Wood, Sarah et al.
University of Pennsylvania
ScholarlyCommons
Botswana-UPenn Scholarly Publications Botswana-UPenn Partnership
8-2009
Epidemiology of Methicillin‐Resistant
Staphylococcus aureus Bacteremia in Gaborone,
Botswana
Sarah Wood
Samir S. Shah
University of Pennsylvania, Samir.Shah@uphs.upenn.edu
Maragaret Bafana
Adam J. Ratner
Peter A. Meaney
University of Pennsylvania, meaney@email.chop.edu
See next page for additional authors
Follow this and additional works at: http://repository.upenn.edu/botswana_schol
Part of the Virus Diseases Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/botswana_schol/45
For more information, please contact libraryrepository@pobox.upenn.edu.
Recommended Citation
Wood, Sarah; Shah, Samir S.; Bafana, Maragaret; Ratner, Adam J.; Meaney, Peter A.; Malefho, Kolaatamo C.S; and Steenhoff, Andrew
P., "Epidemiology of Methicillin‐Resistant Staphylococcus aureus Bacteremia in Gaborone, Botswana" (2009). Botswana-UPenn
Scholarly Publications. 45.
http://repository.upenn.edu/botswana_schol/45
Epidemiology of Methicillin‐Resistant Staphylococcus aureus Bacteremia in
Gaborone, Botswana
Abstract
This cross‐sectional study at a tertiary‐care hospital in Botswana from 2000 to 2007 was performed to
determine the epidemiologic characteristics of Staphylococcus aureus bacteremia. We identified a high
prevalence (11.2% of bacteremia cases) of methicillin‐resistant S. aureus (MRSA) bacteremia. MRSA isolates
had higher proportions of resistance to commonly used antimicrobials than did methicillin‐susceptible
isolates, emphasizing the need to revise empiric prescribing practices in Botswana.
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Epidemiology of Methicillin-Resistant
Staphylococcus aureus Bacteremia
in Gaborone, Botswana
Sarah M. Wood, MD; Samir S. Shah, MD, MSCE;
Margaret Bafana, MS; Adam J. Ratner, MD, MPH;
Peter A. Meaney, MD, MPH;
Kolaatamo C. S. Malefho, MD;
Andrew P. Steenhoff, MD
This cross-sectional study at a tertiary-care hospital in Botswana
from 2000 to 2007 was performed to determine the epidemiologic
characteristics of Staphylococcus aureus bacteremia. We identified a
high prevalence (11.2% of bacteremia cases) of methicillin-resistant
S. aureus (MRSA) bacteremia. MRSA isolates had higher propor-
tions of resistance to commonly used antimicrobials than did meth-
icillin-susceptible isolates, emphasizing the need to revise empiric
prescribing practices in Botswana.
Infect Control Hosp Epidemiol 2009; 30:782-785
In sub-Saharan Africa, Staphylococcus aureus is a common
cause of bacteremia.1-5 High regional prevalence rates of the
human immunodeficiency virus (HIV) may contribute to in-
creased incidence and mortality rates of S. aureus bacteremia.
To our knowledge, the epidemiologic characteristics of S. au-
reus bacteremia in Botswana are unknown.
Knowledge of the epidemiologic characteristics of S. aureus
bloodstream isolates influences treatment decisions and has
broad public health implications.6 Construction of empiric
prescribing guidelines based on local susceptibility profiles
may improve care delivery, optimize available resources, and
decrease mortality.
Our primary objective was to determine the epidemiologic
characteristics of S. aureus bacteremia in hospitalized adults
and children in Gaborone, Botswana, over an 8-year period.
Secondary objectives were to identify patient characteristics
associated with methicillin-resistant S. aureus (MRSA) and to
determine antimicrobial susceptibilities of S. aureus isolates.
methods
This cross-sectional study was performed at Princess Marina
Hospital, a 530-bed hospital in Gaborone, Botswana, with
approximately 25,000 annual admissions. The prevalence of
HIV in Botswana’s adult population is estimated at 17% and
reaches 30%–40% among adults aged 25–44 years. The prev-
alence among children 1.5–4 years of age is 6.3%.7 The in-
patient population of Princess Marina Hospital reflects the
high regional HIV prevalence. Highly active antiretroviral
therapy has been available free of charge since 2002. This
study received approval from the institutional review boards
of the Children’s Hospital of Philadelphia and of Botswana’s
Ministry of Health.
All patients hospitalized at Princess Marina Hospital be-
tween January 2000 and December 2007 and who had a blood
culture that tested positive for S. aureus were eligible for
inclusion; patients with MRSA were compared to those with
methicillin-susceptible S. aureus (MSSA) bacteremia to iden-
tify risk factors for MRSA.
S. aureus bacteremia was defined as a blood culture yielding
S. aureus as the sole pathogen. Polymicrobial blood cultures
were not included. Multiple positive cultures performed on
samples from the same patient within 7 days of the original
culture were excluded. Hospital wards were categorized by
the type of population treated in the ward.
Blood samples were processed using a Signal blood culture
system (Oxoid). Isolation and identification of S. aureus were
performed with Gram stain and coagulase test. Antimicrobial
susceptibility patterns were determined with the disk diffu-
sion method according to Clinical Laboratory Standards In-
stitute guidelines. Methicillin or oxacillin susceptibility was
determined after 24-hour incubation in Mueller-Hinton agar
with 4% sodium chloride. To determine MRSA status, S.
aureus was tested for susceptibility to methicillin from 2000
to 2005 and for susceptibility to oxacillin from 2006 to 2007.
The D test for determining inducible resistance to clinda-
mycin was not routinely performed.
Electronic and manual records of the Botswana National
Health Laboratory were reviewed to identify bacteremic pa-
tients. Demographic data available included age, sex, and
ward location at the time of sampling for blood culture. Pa-
tient HIV status and outcomes were not available. Because
of personnel transitions and the shift from manual to elec-
tronic records, no laboratory records were available for De-
cember 2000 through May 2001 and March 2004 through
October 2005. Because Princess Marina Hospital is a re-
source-constrained setting, blood culture bottles and anti-
biotics were periodically out of stock during the study peri-
od. The sporadic availability of blood culture bottles may
have led to an underestimation of the burden of disease.
Therefore, we report the proportion of patients with S. aureus
bacteremia among all patients with bacteremia.
Continuous variables were described using mean, median,
and range or interquartile range values and compared using
the Wilcoxon rank sum test. Categorical variables were de-
scribed using counts and percentages and compared using
the Fisher exact test.
results
During the study period, 2,310 (29.7%) of 7,779 blood cul-
tures tested positive for a single organism, with S. aureus being
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table. Demographic Characteristics of Patients with Staphylococcus aureus Bacteremia ( )np 538
Patient characteristic
No. (%)
with MSSA
No. (%)
with MRSA
Unadjusted odds ratio
(95% CI) P
Age group ( )anp 488
!1 month 122 (44) 87 (41.2) Reference
1–11.9 months 41 (14.8) 34 (16.1) 1.2 (0.7–1.9) .6
1 year–4.9 years 33 (11.9) 9 (4.3) 0.4 (0.2–0.8) .02
5–14.9 years 25 (9) 8 (3.8) 0.4 (0.2–1) .06
15–49 years 42 (15.1) 50 (23.7) 1.7 (1–2.7) .04
x50 years 14 (5) 23 (10.9) 2.3 (1.1–4.7) .02
Sex ( )np 455
Female 118 (45) 104 (53.9) 1.4 (1–2.1) .01
Ward type ( )np 517
Medical ward 123 (42.3) 92 (40.7) Reference
Surgical ward 27 (9.3) 17 (7.5) 1 (0.7–1.5) .8
Neonatal intensive care unit 124 (42.6) 96 (42.8) 0.8 (0.4–1.6) .6
Adult or pediatric intensive care unit 3 (1) 10 (4.4) 4.4 (1.2–16.6) .03
Obstetrics and gynecology 4 (1.4) 7 (3.1) 2.3 (0.7–8.2) .2
Oncology 3 (1) 1 (0.4) 0.4 (0.04–4.3) .5
Accident and emergency 7 (2.4) 3 (1.3) 0.6 (0.1–2.3) .4
note. CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible
S. aureus.
a Patient-specific information not available for all cases.
figure. Antimicrobial susceptibilities of methicillin-resistant Staphyloccus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA)
isolates. White bars represent percentage of MSSA isolates susceptible to each antimicrobial agent, while black bars represent percentage
of MRSA isolates susceptible to that antimicrobial agent. Overall rates of susceptibility for specific antimicrobial agents were as follows:
chloramphenicol, 77%; erythromycin, 51.3%; clindamycin, 90.8%; vancomycin, 99.2%; tetracycline, 43%; and gentamicin, 64.5%. For
trimethoprim-sulfamethoxazole (TMP-SMX) sample size was insufficient to obtain a significant result.
most commonly isolated. Antibiotic susceptibility results were
available for 538 (92.4%) of 582 blood cultures in which S.
aureus was the sole organism.
The Table displays the demographic characteristics of pa-
tients with S. aureus bacteremia and results of the univariate
analysis. The cohort was 45% female, with a median age of
0.7 years (interquartile range, 0.02–23 years). Compared with
neonates, children aged 1–5 years had reduced odds of having
MRSA, while adult subjects had increased odds of having
MRSA, in both the 15–49 and thex50 years of age categories.
Patients in the intensive care unit had increased odds of
MRSA bacteremia compared with patients on the general
adult medical wards. After adjusting for ward type, we found
that the odds of MRSA bacteremia increased by 9% for each
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5-year increase in age (adjusted odds ratio, 1.09; 95% confid-
ence interval, 1.04–1.16; ).Pp .001
Of the 538 episodes of S. aureus bacteremia with known
susceptibilities, 239 (44.4%) were caused by MRSA. The prev-
alence of S. aureus and MRSA bacteremia among all patients
with confirmed bacteremia and known susceptibility results
( ) was 25.3% ( ) and 11.2% ( ),np 2,129 np 538 np 239
respectively. The median yearly proportion of MRSA among
S. aureus isolates was 44.3% (range, 25.7%–58.3%), with the
peak occurring in 2004.
S. aureus isolates were routinely tested for susceptibility to
chloramphenicol, clindamycin, erythromycin, cephadrine, van-
comycin, tetracycline, gentamicin, and methicillin (Figure).
Susceptibility testing for trimethoprim-sulfamethoxazole was
not routinely performed, and results were available for only
15 isolates. For trimethoprim-sulfamethoxazole susceptibilities,
there was no significant difference between the MSSA and
MRSA groups. MRSA isolates were significantly less susceptible
to all other antimicrobial agents than were MSSA isolates. The
large proportion of isolates resistant to erythromycin but sus-
ceptible to clindamycin suggests the possibility of inducible
resistance to clindamycin.
discussion
Our study demonstrates several important findings about the
epidemiologic characteristics of S. aureus bacteremia in Bo-
tswana. We found a high prevalence of bacteremia caused by
S. aureus, and MRSA in particular, among patients at 1 hos-
pital in an HIV-endemic region. We hope that these results
will catalyze local changes in microbiologic and clinical prac-
tices to allow better surveillance and treatment of invasive S.
aureus infections.
One of the most striking findings in this study is the overall
high proportion of S. aureus bacteremia. In addition, almost
half of the cases of S. aureus bacteremia were due to MRSA.
We also identified several risk factors for MRSA among our
cohort, including increased age and location in the intensive
care unit. This finding is in keeping with previous reports,
which described these risk factors.8,9
Among MRSA isolates, we find high proportions of re-
sistance to antimicrobials commonly used to treat S. aureus
infections. Although more MRSA than MSSA isolates were
resistant to clindamycin, the relatively high proportion of clin-
damycin susceptibility and erythromycin resistance among
MRSA isolates raises the possibility of inducible clindamycin
resistance. Although testing for trimethoprim-sulfamethoxa-
zole was not common, high proportions of both MRSA and
MSSA isolates that were tested were found to be resistant. Our
results underscore the importance of introducing use of the D
test for inducible resistance and of routine testing for resistance
to trimethoprim-sulfamethoxazole in sub-Saharan Africa.
This study had several limitations. The prevalence of both
MRSA and MSSA bacteremia may have been underestimated
due to the inconsistent availability of blood culture bottles.
However, a lack of supplies is an unfortunate reality of med-
ical care in the developing world. We were also unable to
access patient-specific data other than age, sex, and ward.
Therefore, we could not provide mortality data, differentiate
between community-acquired and hospital-acquired infec-
tions, or group patients according to HIV status.
In summary, we report a high prevalence of both MRSA
and MSSA bacteremia in Gaborone, Botswana. The high prev-
alence of MRSA and the increased proportions of resistance
to commonly used antimicrobials among MRSA isolates call
attention to the importance of revising antimicrobial suscep-
tibility testing and empiric prescribing practices in Botswana.
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